In contrast, it SIRT3 was suggested to promote the development of acute myeloid leukemia, diffuse large B cell lymphoma, breast, lung, and colon cancer with various genetic backgrounds (15, 16, 17, 18, 19). This evidence concerns the gene SIRT3 and colonic neoplasm.